发布求助
文献互助 智能选刊 最新文献

Annales chirurgiae et gynaecologiae. Supplementum最新文献

筛选
英文 中文
Diagnostic and therapeutic aspects of adenocarcinoma of the urinary bladder. 膀胱腺癌的诊断与治疗。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
M P Raitanen, P A Hellström, A P Kyllönen, E L Leisti, M J Kontturi
{"title":"Diagnostic and therapeutic aspects of adenocarcinoma of the urinary bladder.","authors":"M P Raitanen,&nbsp;P A Hellström,&nbsp;A P Kyllönen,&nbsp;E L Leisti,&nbsp;M J Kontturi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Twenty cases of adenocarcinoma of the urinary bladder were diagnosed and treated at Oulu University Hospital between 1978 and 1991, comprising nine primary adenocarcinomas (three urachal and six non-urachal) and 11 of extravesical origin (six from the colon, four from the prostate and one from the perineal skin). The prognosis for primary adenocarcinoma after radical surgery was relatively favourable during a follow-up of mean 54 months, but extravesical origin carried a high mortality rate. The diagnostic and therapeutic aspects are discussed.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"43-9"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19280329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphology of osteogenesis in bioactive glass interface. 生物活性玻璃界面成骨的形态学研究。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
A J Aho, J Heikkilä, H J Aho, O Andersson, A Yli-Urpo
{"title":"Morphology of osteogenesis in bioactive glass interface.","authors":"A J Aho,&nbsp;J Heikkilä,&nbsp;H J Aho,&nbsp;O Andersson,&nbsp;A Yli-Urpo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bone formation around bioactive glass implants (S56.5P4) in the trabeculous subchondral bone in the distal femur of rabbits was studied by histology and scanning electron microscopy. Three types of tissue: bone, connective and hematopoietic tissue developed around the implants resulting in lamellar new bone covering 76% of the surface of the implants at twelve weeks. Bone formation around implants began as woven bone changing mainly to lamellar, osteon like new bone in contact with the S56.5P4 surface. Endochondral ossification was absent. In the area of bone containing hematopoietic tissue, new bone grew often as a thin layer along the implant surface. However, bone seemed to form adjacent to the implant surface through osteo-conduction. Only 21% of the implant surface was covered by loose connective tissue. Some proteoglycan containing thin fluid filled spaces were seen ten days after implantation. In few areas with apparent breakdown of the implant surface decreased amount or no bone formation was observed. Von Kossa method stained the reaction layer as two parallel dark brown lines, toluidine blue as two blue stripes, whereas van Gieson did not stain the reaction layer at all. In conclusion, the present histological results indicate bone bonding, which is a physico-chemical process observed between S56.5P4 implant and host bone.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"145-53"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19145982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotesting with high dose prostaglandin E1 in impotence. 大剂量前列腺素E1治疗阳痿的药物试验。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
H Nisén, L Cormio
{"title":"Pharmacotesting with high dose prostaglandin E1 in impotence.","authors":"H Nisén,&nbsp;L Cormio","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The diagnostic value of pharmacotesting in impotence is controversial. The results of high dose prostaglandin pharmacotesting were compared with those of colour duplex Doppler scanning and pharmacocavernometry in 82 impotent patients and 10 control subjects. Based on the results of 10 control subjects, the prostaglandin test was defined as positive if intracavernous pressure 200 minutes after injection of 40 micrograms prostaglandin E1 was > or = 42 mm Hg and negative if intracavernous pressure was < 42 mmHg. The test was repeated in 29 subjects and classified results were consistent in 24 subjects (86%, k = 0.65). The test was negative in 52 out of 56 patients (sensitivity 93%) with vasculogenic impotence (arteriogenic and/or cavernovenous factor involved) and the test was positive in 21 out of 26 patients (specificity 81%) with non-vasculogenic impotence (arteriogenic or cavernovenous factor not involved). The majority, 27 out of 31 patients (87%) with arteriogenic impotence showed simultaneous dysfunction of cavernovenous occlusion mechanism. In conclusion, pharmacotesting with high dose prostaglandin is a useful screening test of vasculogenic impotence.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"63-8"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19278937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments. 浅表性膀胱癌。finn膀胱研究结果及灌注治疗综述。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
K Jauhiainen, E Rintala
{"title":"Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.","authors":"K Jauhiainen,&nbsp;E Rintala","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>At present, about 80% of primary, newly diagnosed urinary bladder cancers are local (NOMO), i.e., potentially curable. Not less than two thirds of all are superficial cancers (TIS, Ta, T1), and thus subjects of conservative, local treatments. Carcinoma in situ (TIS/CIS) has three clinical manifestations: 1) primary TIS is found without a previous history of bladder cancer, 2) secondary TIS is found during the follow-up of an earlier cancer, and 3) concomitant TIS is found simultaneously with a papillary tumour. Otherwise, there are controversial diagnostic and therapeutic attitudes on TIS. Concerning the primary diagnosis and grading, the reliance on cytological possibilities varies in separate centres. \"Wait-and-see policy\" might be justified in mild dysplasia Grade 1, whereas both the TIS Grade 2, and TIS Grade 3, are real malignancies which need a more effective treatment than transurethral resection (TUR) alone. Under a close control, intravesical chemo- and immunotherapy with doxorubicin (ADM), mitomycin C (MMC) and bacillus Calmette-Guérin (BCG) offer an alternative to cystectomy. However, it remains to be seen in the future whether combined or alternating instillations will give a still better return. By contrast, the principal treatment of visible superficial (Ta and T1) cancer is TUR, which can be easily repeated. Most recommended strategy for Grade 3 T1 cancer seems to be the same. Anyhow, the high frequency of recurring tumours and the tendency to simultaneous progression in specific categories of Ta-T1 cancer have led to adjuvant prophylactic instillation treatments. Currently, both local cytostatics (ADM and MMC in the present series), and immunoagents (BCG) have been proven safe.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"31-8"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19280327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of fibrin sealant in osteoinduction. 纤维蛋白密封剂在骨诱导中的作用。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
N Schwarz
{"title":"The role of fibrin sealant in osteoinduction.","authors":"N Schwarz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mesenchymal cell stimulation and angiotropic effects suggest a fibrin sealant-mediated enhancement of osteogenesis. For its glueing capacity fibrin sealant is also regularly used in bone surgery. However, its influence on osteoregeneration is debatable. The effect of fibrin sealant on bone matrix gelatin dependent ectopic and orthotopic osteoinduction in rats was studied. Neither biochemical nor histologic parameters revealed a direct influence of fibrin sealant on any osteoinductive process.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"63-8"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19145959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granular hydroxyapatite and allogeneic demineralized bone matrix in rabbit skull defect augmentation. 颗粒状羟基磷灰石和异体脱矿骨基质在兔颅骨缺损修复中的应用。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
T C Lindholm, T J Gao, T S Lindholm
{"title":"Granular hydroxyapatite and allogeneic demineralized bone matrix in rabbit skull defect augmentation.","authors":"T C Lindholm,&nbsp;T J Gao,&nbsp;T S Lindholm","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To study the effect of hydroxyapatite (HA) granules on new bone formation induced by allogeneic demineralized bone matrix (DBM) and to ascertain the specific dose response of bone regeneration in rabbit calvarial defects, implantation with different doses of DBM, HA granules and a mixture of DBM with HA, respectively, was undertaken. The results showed that the largest quantity of cartilage in the fourth week and woven and remodeled bone covering almost the whole area of the defect in the tenth and twelfth week, was visible in the 20-30 mg but not in the 40 mg DBM groups. New bone formation in the defects implanted with DBM and HA was markedly less than in those implanted with DBM alone and a large amount of fibrous tissue was initiated by HA granules. A significant negative correlation between new bone formation and fibrous tissue ingrowth was noted. HA granules, as disturbing the bone regeneration induced by DBM, are thus not a desirable combination, and a dose-block phenomenon according to the amount of DBM must be anticipated in repairing skull defects.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"91-8"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19146545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group. 磷酸聚stradiol (160 mg/月)或LHRH类似物(buserelin depot)治疗局部晚期或转移性前列腺癌芬前列腺集团。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
J Aro, M Ruutu, H Juusela, E Hansson, J Permi
{"title":"Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.","authors":"J Aro,&nbsp;M Ruutu,&nbsp;H Juusela,&nbsp;E Hansson,&nbsp;J Permi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The clinical efficacy, cardiovascular complications and mortality of polyestradiol phosphate (PEP) 160 mg/month i.m. were compared with the luteinizing hormone releasing hormone (LHRH) analog, buserelin, in a prospective, randomised multicentre study including 147 patients with prostatic cancer. The cumulative non-progression rate at three years was 0.53 in the PEP group and 0.70 in the LHRH group. The mortality from cardiovascular diseases was the same in the two treatment groups. The parenterally given PEP was not associated with an increased risk of cardiovascular complications. The dosage of PEP 160 mg monthly seems, however, to be insufficient in the treatment of prostatic cancer.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"5-8"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19280330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A composite of natural coral, collagen, bone protein and basic fibroblast growth factor tested in a rat subcutaneous model. 天然珊瑚、胶原蛋白、骨蛋白和碱性成纤维细胞生长因子的复合材料在大鼠皮下模型中试验。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
C J Damien, P S Christel, J J Benedict, J L Patat, G Guillemin
{"title":"A composite of natural coral, collagen, bone protein and basic fibroblast growth factor tested in a rat subcutaneous model.","authors":"C J Damien,&nbsp;P S Christel,&nbsp;J J Benedict,&nbsp;J L Patat,&nbsp;G Guillemin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A rat subcutaneous model was used to test the osteoinductive efficacy of a composite consisting of natural coral, collagen, a bone morphogenetic protein-like material [termed bone protein (BP)], and basic fibroblast growth factor (bFGF). Results indicated good ossicle formation only when BP was present, whether with or without bFGF. Initially, cartilage and mineralized cartilage were apparent. With time, osteoblastic bone formation and hematopoietic marrow were evident. bFGF may have enhanced the maturation of the ossicles in the early stages. Coral-collagen appears to be a good carrier vehicle for BP and should be tested in a bony site. This would allow the osteoconductive property of coral to be expressed.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"117-28"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19145978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemi-Kock reconstruction following cystectomy: experience and results from a small urological unit. 膀胱切除术后半kock重建:小泌尿科的经验和结果。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
R Kauppinen, O Lindell
{"title":"Hemi-Kock reconstruction following cystectomy: experience and results from a small urological unit.","authors":"R Kauppinen,&nbsp;O Lindell","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Between December 1988 and January 1992, 11 men underwent lower urinary tract reconstruction by means of the hemi-Kock ileal reservoir following radical cystoprostatectomy (ten patients) and subtotal cystectomy (one patient). Six of the 11 patients developed an early postoperative complication, with a fatal outcome in two of them. One patient succumbed to subarachnoidal bleeding and one to septic shock. During the follow-up, another two men died of advanced bladder carcinoma. The late complication rate was low. Most patients regained their continence within six months. A good continence was achieved in all the nine remaining patients during the day and in six of them at night. This experience suggests that the hemi-Kock reservoir is a useful method for the urinary tract reconstruction following cystectomy.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"39-42"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19280328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional delivery systems for bone inducing proteins. 骨诱导蛋白的功能传递系统。
Annales chirurgiae et gynaecologiae. Supplementum Pub Date : 1993-01-01
{"title":"Functional delivery systems for bone inducing proteins.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"3-161"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19145953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信